NasdaqCM - Delayed Quote • USD
Aethlon Medical, Inc. (AEMD)
At close: April 25 at 4:00 PM EDT
Pre-Market: 5:55 AM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 1 | 2 | 2 |
| Avg. Estimate | -1.25 | -1.09 | -5.22 | -2.63 |
| Low Estimate | -1.41 | -1.09 | -5.34 | -4.4 |
| High Estimate | -1.1 | -1.09 | -5.1 | -0.86 |
| Year Ago EPS | -1 | -1.4 | -5.9 | -5.22 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | 574k | -- | 574k | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -1.3 | -1.3 | -1.4 | -1.23 |
| EPS Actual | -1 | -1.4 | -1.22 | -1.37 |
| Difference | 0.3 | -0.1 | 0.18 | -0.14 |
| Surprise % | 23.10% | -7.70% | 12.90% | -11.40% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -1.25 | -1.09 | -5.22 | -2.63 |
| 7 Days Ago | -1.25 | -1.09 | -5.22 | -2.63 |
| 30 Days Ago | -1.25 | -1.09 | -5.22 | -2.63 |
| 60 Days Ago | -1.14 | -1.09 | -5.04 | -4.83 |
| 90 Days Ago | -1.18 | 0 | -4.98 | -5.27 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | AEMD | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -25.00% | -- | -- | 2.60% |
| Next Qtr. | 22.10% | -- | -- | 13.40% |
| Current Year | 11.50% | -- | -- | 5.20% |
| Next Year | 49.60% | -- | -- | 13.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.11% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/4/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 10/24/2023 |
Related Tickers
CTSO Cytosorbents Corporation
0.8090
-1.55%
BBLGW Bone Biologics Corporation
23.04
+15.14%
OPGN OpGen, Inc.
0.5320
-5.51%
RSLS ReShape Lifesciences Inc.
0.1780
+5.89%
BBLG Bone Biologics Corporation
1.5200
-1.94%
IINN Inspira Technologies Oxy B.H.N. Ltd.
1.8800
-2.59%
CVRX CVRx, Inc.
14.39
-0.07%
QIPT Quipt Home Medical Corp.
3.6600
-4.69%
HSDT Helius Medical Technologies, Inc.
4.4400
-6.72%
DC4.DE DexCom, Inc.
120.50
-5.06%